Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study

Background ARCADIA (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke), a secondary stroke prevention study comparing apixaban versus aspirin for cryptogenic stroke and biomarkers of atrial cardiopathy, ended prematurely for futility. In the ARCADIA‐Cognition study w...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ronald M. Lazar, George Howard, Michael T. Brewer, Christy Cassarly, Qi Pauls, Stephanie Kemp, David L. Tirschwell, Kevin N. Sheth, Max Wintermark, Hooman Kamel, W. T. Longstreth Jr, Mitchell S.V. Elkind, Joseph P. Broderick, Maarten G. Lansberg
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-09-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	Apixaban aspirin atrial cardiopathy cognition covert infarction
Acceso en liña:	https://www.ahajournals.org/doi/10.1161/JAHA.125.042147
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!